Innovative cancer research will be awarded with travel, accommodation, and registration fee compensation to the EACR 2022 Congress in Seville. In addition, the winner will have the opportunity to share their research with the scientific community.
Submit your abstract within the given timeline to apply for this travel award.
Entry deadline: May 30, 2022
Winner announced: June 10, 2022
The Immuno-Oncology Innovation Award (IOIA) is open to all established scientists, clinicians, postdoctoral scientists, trainee clinicians, PhD and Masters students working within the field of immuno-oncology research.
All participants must have their abstract accepted for a poster or oral presentation at the EACR 2022 Congress prior to submitting it for the Immuno-Oncology Innovation Award (IOIA) 2022. The accepted abstract for the IOIA must be submitted through the form below by May 30, 2022.
All applications will be reviewed by three reviewers with the winner being announced via e-mail by June 10, 2022. One selected winner will be awarded with fully funded travel, accommodation, and registration fee (up to €1500).
Seems like you are coming from USA!
Do you want to visit our website in your country?